Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of ...

Mural Oncology plc, acting as the offeree in a takeover situation, has disclosed its opening position as of April 29, 2025, under the Irish Takeover Panel Rules.

Circulating tumor DNA (ctDNA) is an emerging tool in the evaluation of GI cancers. Challenges remain in defining its utility and role as a primary end point in therapeutic trials. The National Cancer ...

BridgeBio Oncology aims to drug KRAS G12C in both the “on” and “off” states with a drug codenamed BBO-8520. A Phase 1 study is testing this drug in patients with non-small cell lung cancer ...

Chief Oncology Officer and Executive Vice President Chris Boshoff, M.D., Ph.D., took on Dolsten’s position at the start of 2025, with Dansey stepping into Boshoff’s old role.

Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 Jan. 14, 2025 10:51 PM ET Arcus Biosciences, Inc. (RCUS) Stock GILD, RCUS 2 Comments 1 Like Myriam Alvarez 2.61K Follower s ...

These investments are mostly held in commercial paper and corporate bonds, so they seem relatively liquid, from what I can tell. Source: BDTX’s latest 10-Q report.

News provided by EIN Presswire Dec 04, 2024, 2:13 PM ET ...

Mercy Corps’ Climate: Possible position paper series articulates proven and high-potential solutions to climate challenges, drawing on Mercy Corps’ extensive experience, evidence, and insights ...